Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma

ABSTRACT Hepatocellular carcinoma (HCC) remains the most prevalent primary liver cancer, characterized by alarmingly high mortality rates and low five‐year survival outcomes. A significant challenge in HCC management lies in its advanced‐stage treatment, with most cases identified at advanced, unres...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yongxin Yu, Yulang Jiang, Yipeng Yang, Christian Glandorff, Wenzheng Fang, Mingyu Sun
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2026-01-01
Edice:	Global Challenges
Témata:	hepatocellular carcinoma immune checkpoint inhibitor lenvatinib sorafenib systemic treatment tyrosine kinase inhibitor
On-line přístup:	https://doi.org/10.1002/gch2.202500247
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!